Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases
Year: 2013
Type: review
DOI: 10.1111/nyas.12122
Institutions: Novartis (United States), Novartis (Switzerland)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1900079465
